InvestorsHub Logo

terry hallinan

04/13/18 4:09 PM

#5997 RE: buckiii2 #5996

Does this CEO buy stock every day or so?

No, Buck.

Frost is indeed a hefty buyer of his own stock but there was a notable absence when he seemed to concentrate on ELOX, which he bought for his family fund as well as OPK along with other well-heeled investors

An examination of ELOX shows a possible monster stock springing to life like Venus on the Half Shell or another abject failure which could soon vanish.

http://www.eloxxpharma.com/

The task of curing - curing, not just treating - nonsense diseases [from antisense lingo] is awesome. Two of the most common groups of allied diseases with incomplete protein transmission are muscular dystrophy and cystic fibrosis.

IMHO the two medical improvements most harped on by analysts - 4KScore and Rayaldee - are quite minor factors in the building of OPK compared to the various genetic targets though by themselves hardly unimportant.

JMO, friend. Use your best judgment. My limited years of investing in OPK has yielded nothing but red ink as must be true for the "Warren Buffett of Biotech."

Best, Terry

tredenwater2

04/15/18 6:40 AM

#5998 RE: buckiii2 #5996

Hi Buckiii2

In short....yes. Dr. Frost buys on the open market whenever and however much he feels like on any particular day. When he buys opko stock, he is also buying many other companies at the same time.

http://www.opko.com/strategic-investments/overview/

Investors use to be so consumed in the timing of his buys and his "quiet periods". If your new to Opko than I recommend doing your own DD and be patient. One advantage you have over others is that this is a very attractive entry price. Many have had to try to average down over the years.

I am currently NOT invested in OPKO but have been and have followed this company since early 2013. At some point I may reenter. One thing I can honestly say is that the man has a plan and my best guess is that he will own or control %51 of this company before the profits start to roll in heavy. Also his %51 ownership IMO will be before Opko's drug for obesity called oxyntomodulin hits the market. This is one pet project he is most fond of and rightfully so. If this (failed Merck drug redesigned with CTP technology added) once a week diet drug works as planned, the market share is in the tens of billions!

The man is a genius when it comes to business building and designing drugs. He has great foresight and patience extending out 5-10 years. Many believe because of his age that this is his third and final business that he is/has built.

Its truly been a long haul for many investors as you can easily see by the rollercoaster ride in pps. Either your a believer in Dr. Frost and his ability to eventually bring this company home to roost for investors or not.


Good luck

Tred